Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | EDNRA | P25101 | 5/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12306590 | 0.87 | KDM4E (0.43) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL13443593 | 0.87 | L3MBTL1 (0.45) | KDM4EATML3MBTL1EDNRAPTGER4 | |
| SCHEMBL18622807 | 0.87 | L3MBTL1 (0.45) | KDM4EATML3MBTL1EDNRAPTGER4 | |
| SCHEMBL18622803 | 0.87 | L3MBTL1 (0.47) | KDM4EATML3MBTL1EDNRAPTGER4 | |
| SCHEMBL13444136 | 0.87 | L3MBTL1 (0.50) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL12306534 | 0.87 | L3MBTL1 (0.50) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL13443606 | 0.87 | L3MBTL1 (0.50) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL13557595 | 0.85 | L3MBTL1 (0.46) | KDM4EATML3MBTL1EDNRAPTGER4 | |
| SCHEMBL13444300 | 0.85 | L3MBTL1 (0.49) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL13444405 | 0.85 | L3MBTL1 (0.49) | KDM4EATML3MBTL1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10249830-B2 | Carbazole-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-02 | — | — | US | disclosed |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-16 | — | — | US | disclosed |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10249830-B2 | Carbazole-based compound and organic light-emitting device including the same | OCIAD1, OXA1L, OCIAD2 | KDM4E 3223/4885ATM 3873/4885L3MBTL1 50/4885 |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | OCIAD1, OXA1L, CYP1A1 | KDM4E 3224/4885ATM 3712/4885L3MBTL1 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.